These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12954135)

  • 1. Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism.
    Jönsson H; Mattsson S
    Cancer Biother Radiopharm; 2003 Jun; 18(3):473-9. PubMed ID: 12954135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of the radioiodine test for the calculation of the therapeutic dose in benign thyroid diseases].
    Nüchel C; Boddenberg B; Schicha H
    Nuklearmedizin; 1993 Apr; 32(2):91-8. PubMed ID: 8479936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients.
    Canzi C; Zito F; Voltini F; Reschini E; Gerundini P
    Med Phys; 2006 Aug; 33(8):2860-7. PubMed ID: 16964862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity application.
    Reinartz P; Zimny M; Schaefer W; Mueller B; Buell U; Sabri O
    Nucl Med Commun; 2003 Dec; 24(12):1247-53. PubMed ID: 14627852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
    J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up on thyroidal uptake after radioiodine therapy: how robust is the peri-therapeutic dosimetry?
    Eschner W; Kobe C; Schicha H
    Z Med Phys; 2011 Dec; 21(4):258-65. PubMed ID: 21719262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two-step radioiodine therapy in benign thyroid diseases during a single hospital visit--observations on 100 patients].
    Khandani A; Schicha H
    Nuklearmedizin; 1999; 38(5):140-3. PubMed ID: 10488480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' disease radioiodine-therapy: choosing target absorbed doses for therapy planning.
    Willegaignon J; Sapienza MT; Coura-Filho GB; Watanabe T; Traino AC; Buchpiguel CA
    Med Phys; 2014 Jan; 41(1):012503. PubMed ID: 24387527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.
    Melo DR; Brill AB; Zanzonico P; Vicini P; Moroz B; Kwon D; Lamart S; Brenner A; Bouville A; Simon SL
    Radiat Res; 2015 Dec; 184(6):595-610. PubMed ID: 26579944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount.
    Schiavo M; Bagnara MC; Pomposelli E; Altrinetti V; Calamia I; Camerieri L; Giusti M; Pesce G; Reitano C; Bagnasco M; Caputo M
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):301-7. PubMed ID: 23486350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary?
    Bajnok L; Mezosi E; Nagy E; Szabo J; Sztojka I; Varga J; Galuska L; Leovey A
    Thyroid; 1999 Sep; 9(9):865-9. PubMed ID: 10524564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma.
    Hermanská J; Kárný M; Zimák J; Jirsa L; Sámal M; Vlcek P
    J Nucl Med; 2001 Jul; 42(7):1084-90. PubMed ID: 11438632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical Note: Determination of individual thyroid clearance effective half-life with a common handheld electronic dosimeter.
    Fürstner M; Hentschel M; Spanjol PM; Prenosil GA; Weidner S; Krause T; Klaeser B
    Med Phys; 2017 Apr; 44(4):1558-1562. PubMed ID: 28206679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry prior to I-131-therapy of benign thyroid disease.
    Hänscheid H; Lassmann M; Reiners C
    Z Med Phys; 2011 Dec; 21(4):250-7. PubMed ID: 21531122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.